Randomized phase II study of neoadjuvant (neoadj) anti-PD-1 dostarlimab (D) vs. D + anti-TIM-3 cobolimab (C) in high-risk resectable melanoma (mel) (NEO-MEL-T): Primary analysis. A randomized phase 2 ...
Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncology, Establishing Scientific Foundation for the Landmark GPS-ProtecT Randomized C ...
The first randomized, controlled trial for a common childhood eating disorder has shown how therapists and parents can help ...
Morning Overview on MSNOpinion
A once-a-day pill nearly doubled survival for patients with advanced pancreatic cancer in a 500-person trial
Patients with previously treated metastatic pancreatic cancer lived roughly twice as long when given an oral pill called ...
A new study published in The Annals of Family Medicine found that adult patients experienced significant pain and anxiety ...
KEYMAKER-U01E: A phase 2 umbrella study with rolling arms of investigational agents with or without chemotherapy plus pembrolizumab for resectable stage II–IIIB (N2) non–small-cell lung cancer (NSCLC) ...
Recent research has overturned the idea that self-critical behavior fosters resilience. An innovative study demonstrated that ...
Malaria control and elimination is threatened by the spread of insecticide resistance and behavioral adaptation of vectors. Whether mass administration of ivermectin, a broad-spectrum antiparasitic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results